Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Biomarker Study for the Evaluation of Response and Validation of Endotypes in Acute Respiratory Distress Syndrome

NCT07675265 is registered in ClinicalTrials.gov with Prenosis, Inc. as lead sponsor.

NCT NCT07675265
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07675265 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Biomarker Study for the Evaluation of Response and Validation of Endotypes in Acute Respiratory Distress Syndrome
Lead sponsor
Prenosis, Inc.
Phase
Observational
Overall status
Recruiting
Start date
September 14, 2026
Completion date
March 31, 2029
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards (acute respiratory distress syndrome)